Balversa 4 MG tablet 28S
Ended Awarded
- Contract number
- SPE2DB25FJB13
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,448
Award facts
- Contract value 100% obligated
- $14,447.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Balversa 4 mg tablets (28-count package) under a firm fixed-price contract valued at $14,447.65, with completion targeted for August 14, 2025. The contract represents a non-set-aside, competitively awarded delivery order to be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. This award falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive pharmaceutical support mechanism for military and federal healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a registered federal contractor specializing in medical procurement for defense and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries through the Defense Logistics Agency, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The current delivery order for Balversa represents a component of the company's ongoing pharmaceutical supply obligations to support military healthcare programs and the Defense Health Agency.
Quick answers
Who was awarded contract SPE2DB25FJB13?
SPE2DB25FJB13 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FJB13 worth?
The government has obligated $14,448 on SPE2DB25FJB13.
Is contract SPE2DB25FJB13 an order under another contract?
Yes. SPE2DB25FJB13 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJB13 competed?
The extent of competition for SPE2DB25FJB13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award